Atria Wealth Solutions, Inc. Belite Bio, Inc Transaction History

Atria Wealth Solutions, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$12.53 - $36.64 $9.28 Million - $27.1 Million	-740,479 Reduced 90.91%	74,019 $2.36 Million
Q2 2023 Aug 03, 2023	BUY	$11.18 - $30.2 $30,554 - $82,536	2,733 Added 0.34%	814,498 $11.6 Million
Q1 2023 Aug 22, 2023	SELL	$25.61 - $33.5 $61,464 - $80,400	-2,400 Reduced 0.29%	812,098 $24.3 Million
Q1 2023 Jun 14, 2023	SELL	$25.61 - $33.5 $8,528 - $11,155	-333 Reduced 0.04%	811,765 $24.3 Million
Q1 2023 May 10, 2023	BUY	$25.61 - $33.5 $8,528 - $11,155	333 Added 0.04%	812,098 $24.3 Million
Q4 2022 Aug 30, 2023	SELL	$25.08 - $33.32 $68,543 - $91,063	-2,733 Reduced 0.34%	811,765 $24.5 Million
Q4 2022 Feb 13, 2023	BUY	$25.08 - $33.32 $19 Million - $25.2 Million	757,560 Added 1397.58%	811,765 $24.5 Million
Q3 2022 Nov 14, 2022	BUY	$22.57 - $44.0 $107,026 - $208,648	4,742 Added 9.59%	54,205 $1.82 Million
Q2 2022 Aug 15, 2022	BUY	$8.87 - $34.28 $438,736 - $1.7 Million	49,463 New	49,463 $1.54 Million

187K

Ticker BLTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,867,400
Market Cap $1.16B
Description
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.